The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Epclusa (sofosbuvir and velpatasvir)

How can I get assistance paying for Epclusa? Is Epclusa covered by insurance?

UPDATE: In 2019 Gilead, the developer of Epclusa, authorized a generic version of Epclusa.

Gilead created a Support Path™ to provide assistance to patients who are uninsured, underinsured or need financial assistance to pay for Epclusa. For more information visit

Additionally, Gilead is providing a co-pay coupon to pay no more than $5 per co-pay for those that are eligible. For more details and to register visit

Contact your insurance company directly for information regarding coverage of Epclusa.


Last Updated: January 2019


"Co-pay Coupon | EPCLUSA®." Gilead Sciences, Inc., Retrieved June 29, 2016

"Highlights of Prescribing Information." Retrieved June 29, 2016.

"Support Path Harvoni® and Epclusa® Tablets Treatment Support." Gilead Sciences, Inc., Retrieved June 29, 2016.

"U.S. Food and Drug Administration Approves Gilead's Epclusa (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C.". Retrieved June 29, 2016.